Patients should have affordable and quality medicines

COVID-19 has exacerbated many health issues that require a range of amendments and additions to current health legislation. How the coronavirus pandemic affected the provision of medicines to Russians, we will consider together with industry experts, legislators and regulators in a hybrid format within the framework of the Partnership “Medicines of Russia — for an interdisciplinary dialogue”. The speakers of the forum in Kaliningrad will meet at a round table, and all participants will be able to register right now and join the discussion online from anywhere in the world. We start on September 25 at 10 o’clock Moscow time.

Traditionally, the discussion is centered on the problem of purchasing drugs for beneficiaries. During the pandemic, many patients with chronic diseases faced difficulties in obtaining subsidized drugs, with a lack of information on how to obtain the necessary drugs during self-isolation. For some nosologies and regions, this process was adjusted, including due to help of volunteers, for others, patients went through all the circles of hell.

According to the chairman of the State Duma Committee on Health Protection, a deputy of the United Russia faction, Dmitry Morozov, specific patients should receive a specific drug. In the proposal for the bill on palliative medicine, this year an additional decision was made to allocate 10 billion rubles for pain relievers, separate funds were allocated for the purchase of drugs for patients with cardiovascular pathologies and cerebrovascular accidents.

In accordance with order of President Vladimir Putin, a federal register of citizens entitled to receive free medicines has been launched in Russia. It should increase the transparency of the system for providing subsidized medicines and reduce the burden on the budget of Russian Federation. According to the Government of the Russian Federation, in 2020, 177 billion rubles were allocated for drug provision of Russians. Of these, 51 billion rubles will be spent on the purchase of medicines for beneficiaries.

The expert community will pay special attention to the modernization of the drug supply system for citizens and the prospects for the implementation of pilot projects. In addition, experts will discuss issues of pricing, improving legislation in the field of drug circulation, increasing the efficiency of state procurement, developing the domestic pharmaceutical market, identifying and suppressing cartels and other anticompetitive agreements in the supply of medicines and medical devices. Administrative and arbitration practice will be considered. The project of Pharma 2030 strategy  will not be ignored either.

“The September events in Kaliningrad have already become a tradition. Of course, such events are very useful. The Forum is a unique platform for productive discussion of the widest range of issues on interaction in the field of drug provision. Thanks to live communication, there is a clear understanding of what the pharmaceutical industry can offer for the most effective treatment of certain diseases, ”said Alexander Kravchenko, Minister of Health of the Kaliningrad Region.

The peculiarity of the Partnership is its wide availability. The event will be broadcasted on the ARPM youtube channel, that will allow everyone to join the discussion and express their opinion or ask a question to the speakers. Registration is open. The application for connection must be sent to the e-mail

Their participation in the discussion was confirmed by: Deputy of the State Duma Alexander Petrov, Senator Tatyana Kusayko, Director of the Department of Pharmaceutical Provision and Regulation of the Circulation of Medical Devices of the Ministry of Health of Russia Elena Maksimkina, Deputy Head of Federal Service for Surveillance in Healthcare (Roszdravnadzor) Dmitry Parkhomenko, General Director of the Federal State Budgetary Institution " Center for expertise and quality control of medical care" Vitaly Omelyanovsky, Head of the Department of Health Control FAS Russia Elena Kloster, Deputy Head of the Department for Combating Cartels of the FAS Russia Yekaterina Konopkina and others.

Recall that the Partnership “Medicines of Russia — for an interdisciplinary dialogue” was launched in 2013. Since 2018, the forum has been held in the amber capital with the support of the Ministry of Health of the Kaliningrad Region.

Media partners of the event: GMP news, Pharma RF, Moscow pharmacies, Komsomolskaya Pravda, Regions of Russia, the scientific journal Development and Registration of Medicines, the Pro (about) Business TV channel.

Пресс-служба АРФП